ASMB (Assembly Biosciences) Accounts Payable: $1.13 Mil (As of Mar. 2026)


ASMB Assembly Biosciences Inc ASMB
32 GF Score
Price $26.74
! 3 Warning Signs
View Full Analysis

What is Assembly Biosciences Accounts Payable?

Assembly Biosciences ASMB +10.25% 32 Accounts Payable is $1.13 Mil as of Mar. 2026. GuruFocus rates ASMB with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

Assembly Biosciences's Accounts Payable for the quarter that ended in Mar. 2026 was $1.13 Mil.

Assembly Biosciences's quarterly Accounts Payable declined from Sep. 2025 ($1.68 Mil) to Dec. 2025 ($1.17 Mil) and declined from Dec. 2025 ($1.17 Mil) to Mar. 2026 ($1.13 Mil).

Assembly Biosciences's annual Accounts Payable increased from Dec. 2023 ($0.46 Mil) to Dec. 2024 ($0.59 Mil) and increased from Dec. 2024 ($0.59 Mil) to Dec. 2025 ($1.17 Mil).

Assembly Biosciences Accounts Payable Related Terms

Assembly Biosciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Assembly Biosciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Assembly Biosciences Accounts Payable Chart

Assembly Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.66 2.49 0.46 0.59 1.17

Assembly Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.88 0.74 1.68 1.17 1.13
ASMB
32GF Score
Assembly Biosciences Inc ASMB
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Assembly Biosciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $1.13 Mil mean?
Assembly Biosciences (ASMB) has a Accounts Payable of $1.13 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Assembly Biosciences and its competitors.
Is Assembly Biosciences' Accounts Payable too high?
Assembly Biosciences' current Accounts Payable is $1.13 Mil. Overall, Assembly Biosciences has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Assembly Biosciences' Accounts Payable compare to MDXG and AGMB?
Assembly Biosciences' Accounts Payable of $1.13 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Assembly Biosciences and its competitors. Assembly Biosciences's current Accounts Payable is $1.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Assembly Biosciences stock overvalued right now?
Assembly Biosciences (ASMB) has a current Accounts Payable of $1.13 Mil. The current Accounts Payable is $1.13 Mil. Assembly Biosciences' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Assembly Biosciences (ASMB), the current Accounts Payable is $1.13 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Assembly Biosciences Business Description

Other Exchanges V7B:Germany
Address Two Tower Place, 7th Floor, South San Francisco, CA, USA, 94080
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
32GF Score

Get the complete analysis for ASMB

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.74
Price